期刊论文详细信息
Journal of Nanobiotechnology
Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging
Research
Khalid M. Abu-Salah1  Fei Ye2  Ibrahim El-Serafi2  Manuchehr Abedi-Valugerdi2  Ramy El-Sayed2  Åsa Barrefelt2  Moustapha Hassan3  Ying Zhao3  Mamoun Muhammed4  Heba Asem5  Jörg Hamm6 
[1] Department of Nanomedicine, King Abdullah International Medical Research Center, King Abdulaziz Medical City, PO Box 22490, 11426, Riyadh, Saudi Arabia;Division of Experimental Cancer Medicine (ECM), Department of Laboratory Medicine (LABMED), Karolinska Institutet (KI), 141 86, Stockholm, Sweden;Division of Experimental Cancer Medicine (ECM), Department of Laboratory Medicine (LABMED), Karolinska Institutet (KI), 141 86, Stockholm, Sweden;Clinical Research Center (KFC), Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden;Division of Functional Materials (FNM), Department of Materials and Nanophysics, Royal Institute of Technology (KTH), 164 40, Stockholm, Sweden;Division of Functional Materials (FNM), Department of Materials and Nanophysics, Royal Institute of Technology (KTH), 164 40, Stockholm, Sweden;Division of Experimental Cancer Medicine (ECM), Department of Laboratory Medicine (LABMED), Karolinska Institutet (KI), 141 86, Stockholm, Sweden;PerkinElmer, 68 Elm St., 01748, Hopkinton, MA, USA;
关键词: Biodegradable polymer;    Drug delivery;    Magnetic resonance imaging;    In vivo fluorescence imaging;    Biodistribution;    Busulphan;    Cancer;   
DOI  :  10.1186/s12951-016-0239-0
 received in 2016-10-06, accepted in 2016-12-03,  发布年份 2016
来源: Springer
PDF
【 摘 要 】

BackgroundMultifunctional nanocarriers for controlled drug delivery, imaging of disease development and follow-up of treatment efficacy are promising novel tools for disease diagnosis and treatment. In the current investigation, we present a multifunctional theranostic nanocarrier system for anticancer drug delivery and molecular imaging. Superparamagnetic iron oxide nanoparticles (SPIONs) as an MRI contrast agent and busulphan as a model for lipophilic antineoplastic drugs were encapsulated into poly (ethylene glycol)-co-poly (caprolactone) (PEG-PCL) micelles via the emulsion-evaporation method, and PEG-PCL was labelled with VivoTag 680XL fluorochrome for in vivo fluorescence imaging.ResultsBusulphan entrapment efficiency was 83% while the drug release showed a sustained pattern over 10 h. SPION loaded-PEG-PCL micelles showed contrast enhancement in T2*-weighted MRI with high r2* relaxivity. In vitro cellular uptake of PEG-PCL micelles labeled with fluorescein in J774A cells was found to be time-dependent. The maximum uptake was observed after 24 h of incubation. The biodistribution of PEG-PCL micelles functionalized with VivoTag 680XL was investigated in Balb/c mice over 48 h using in vivo fluorescence imaging. The results of real-time live imaging were then confirmed by ex vivo organ imaging and histological examination. Generally, PEG-PCL micelles were highly distributed into the lungs during the first 4 h post intravenous administration, then redistributed and accumulated in liver and spleen until 48 h post administration. No pathological impairment was found in the major organs studied.ConclusionsThus, with loaded contrast agent and conjugated fluorochrome, PEG-PCL micelles as biodegradable and biocompatible nanocarriers are efficient multimodal imaging agents, offering high drug loading capacity, and sustained drug release. These might offer high treatment efficacy and real-time tracking of the drug delivery system in vivo, which is crucial for designing of an efficient drug delivery system.

【 授权许可】

CC BY   
© The Author(s) 2016

【 预 览 】
附件列表
Files Size Format View
RO202311108185823ZK.pdf 6517KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  文献评价指标  
  下载次数:1次 浏览次数:1次